News

AddToAny

Google+ Facebook Twitter Twitter

Blood sample analysis

Nightingale Health will analyse the biomarker profiles of 500,000 blood samples from UK Biobank. 

p8-13-News-Blood-testing--Istock--520292052.jpg

Nightingale’s biomarker profiling technology will be used to analyse UK Biobank blood samples by measuring metabolic biomarkers that recent studies have found are predictive of future risk for heart disease, type 2 diabetes and many other common chronic diseases.

Until recently, technological constraints and prohibitive costs have prevented the analysis of comprehensive metabolic data from large-scale biobank collections.

nightingalehealth.com
 

Image credit | iStock

Related Articles

Medical conference, educational meeting of doctors scientists vector illustration.CREDIT - Shutterstock-1635771265

The Big Question: Modernising Scientific Careers

This month we ask: Modernising Scientific Careers was hoped to address skills shortages by standardising education and training pathways. How successful in this do you think it has been?

Liquid biopsy evaluation-CREDIT - syantra-inc-20211117

Liquid biopsy evaluation

Researchers have received a $2.4m grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.

David Wells

The adoption of home testing

IBMS Chief Executive David Wells on ensuring home testing is implemented in a safe, effective and ethical manner.

New born blood-credit-istock-1187337604

Newborn screening

Dr Ben Sholademi, a Senior Clinical Scientist, looks at the work carried out at the Regional Newborn Screening Laboratory.

Top